Health-related quality of life for immediate versus delayed androgen-deprivation therapy in patients with asymptomatic, non-curable prostate cancer (TROG 03.06 and VCOG PR 01-03 [TOAD]): A randomised, multicentre, non-blinded, phase 3 trial

Citation

Duchesne, G, Woo, H, King, M et al 2017, 'Health-related quality of life for immediate versus delayed androgen-deprivation therapy in patients with asymptomatic, non-curable prostate cancer (TROG 03.06 and VCOG PR 01-03 [TOAD]): A randomised, multicentre, non-blinded, phase 3 trial', Lancet Oncology, The, vol. 18, no. 9, pp. 1192-1201.

Year

2017

Field of Research

  • Public Health And Health Services Not Elsewhere Classified

Updated:  20 June 2019 / Responsible Officer:  Director (Research Services Division) / Page Contact:  Researchers